Chiesi Ventures


Chiesi Ventures is a venture capital firm dedicated to investing in early-stage development opportunities in the field of rare and orphan disorders. The firm aims to complement the strategic interests of the Chiesi Group by fostering innovation and expanding its network in Europe and the US. Chiesi Ventures focuses on improving diagnosis, disease management, and therapy for patients affected by rare diseases, leveraging strategic collaborations and a global presence to drive impactful research and development.

Chiesi Ventures

Chiesi Ventures

One Boston Place, #4000, Boston, MA 02109 (US)


Portfolio

Focused on developing therapies for rare and orphan diseases.

#Biopharmaceuticals

Developing therapies for orphan diseases, with a focus on PMM2-CDG.

#Biotechnology

Harnessing directed evolution for targeted genetic medicines.

#Biotherapeutics

Developing virus-like drug conjugate therapies for oncology indications.

#Biotechnology

Focused on therapies for rare genetic mitochondrial diseases.

#Pharmaceuticals

Developing therapies for orphan CNS disorders.

#Biotechnology

JOIN OUR MAILING LIST

Stay Connected with MTEC

Keep up with active and upcoming solicitations, MTEC news and other valuable information.